Novo Nordisk recognizes that some patients find it difficult to pay for healthcare, including insulin. As such, the company remains committed to reducing the burden of out-of-pocket costs, helping transform the complex pricing system, and fostering better pricing predictability. Novo Nordisk continually reviews and revises our offerings and works with diverse stakeholders to create solutions for differing patient needs.
We encourage anyone in need to go to NovoCare.com to learn more.
Copay and Patient Assistance Program offerings: